MED1 and colorectal carcinoma: Unlike other tCDKs, CDK8/CDK19 act as potent repressors of SE-associated gene expression in CRC.360 Consistently, in CRC xenograft models, pharmacological inhibition of CDK8 and CDK19 resulted in gene expression profiles consistent with increased super-enhancer activity at MED1-marked associated genes.360